Posted On: 01/04/2015 9:38:13 AM
Post# of 30066
I understand that...that was my I am all doom and gloom because the Steelers lost next morning whine post.
In regards to a lympro spinoff 2Q sounds great but lets be honest here....its not....maybe Q4 but this timetable is no different than other event timetables like updating to NASDAQ 4Q/2014
It keeps us on our toes wondering what is being done behind the scenes with Lympro that they are perceiving 2Q as the right time for a spinoff????
The only deadlines I would expect Gerald to hit are the ones they do not control like Orphan designations...those times its the FDA meeting the date
All that being said....I'm excited for upcoming conferences and to hopefully hear more about Lympro. However would not be surprised if we get data which we expected accompanied by some PR that looks delicious at first glance but by the time you get to "About Alzheimers Disease" its evident that you will remain hungry.
I better go eat my snickers...
In regards to a lympro spinoff 2Q sounds great but lets be honest here....its not....maybe Q4 but this timetable is no different than other event timetables like updating to NASDAQ 4Q/2014
It keeps us on our toes wondering what is being done behind the scenes with Lympro that they are perceiving 2Q as the right time for a spinoff????
The only deadlines I would expect Gerald to hit are the ones they do not control like Orphan designations...those times its the FDA meeting the date
All that being said....I'm excited for upcoming conferences and to hopefully hear more about Lympro. However would not be surprised if we get data which we expected accompanied by some PR that looks delicious at first glance but by the time you get to "About Alzheimers Disease" its evident that you will remain hungry.
I better go eat my snickers...
(0)
(0)
